Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Albemarle Corporation stock logo
ALB
Albemarle
$131.29
+0.1%
$136.81
$71.25
$221.00
$15.47B1.332.37 million shs2.42 million shs
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
$1.47
+3.5%
$1.14
$0.88
$1.71
$164.56M0.721.08 million shs1.52 million shs
SmartRent, Inc. stock logo
SMRT
SmartRent
$1.36
-4.6%
$1.10
$0.91
$2.20
$272.09M1.522.01 million shs1.37 million shs
10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Albemarle Corporation stock logo
ALB
Albemarle
-0.17%+10.76%+4.15%-36.16%+74.22%
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
+3.52%+12.21%+45.54%+8.89%+49.10%
SmartRent, Inc. stock logo
SMRT
SmartRent
-4.24%+33.50%+29.67%+18.34%+7.11%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Albemarle Corporation stock logo
ALB
Albemarle
$131.29
+0.1%
$136.81
$71.25
$221.00
$15.47B1.332.37 million shs2.42 million shs
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
$1.47
+3.5%
$1.14
$0.88
$1.71
$164.56M0.721.08 million shs1.52 million shs
SmartRent, Inc. stock logo
SMRT
SmartRent
$1.36
-4.6%
$1.10
$0.91
$2.20
$272.09M1.522.01 million shs1.37 million shs
10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Albemarle Corporation stock logo
ALB
Albemarle
-0.17%+10.76%+4.15%-36.16%+74.22%
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
+3.52%+12.21%+45.54%+8.89%+49.10%
SmartRent, Inc. stock logo
SMRT
SmartRent
-4.24%+33.50%+29.67%+18.34%+7.11%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Albemarle Corporation stock logo
ALB
Albemarle
2.50
Moderate Buy$190.2644.92% Upside
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
2.33
Hold$8.50478.23% Upside
SmartRent, Inc. stock logo
SMRT
SmartRent
1.67
Reduce$1.20-11.44% Downside

Current Analyst Ratings Breakdown

Latest ALB, CRDL, SMRT, and CRTA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/10/2026
Albemarle Corporation stock logo
ALB
Albemarle
Lower Price TargetSector Outperform$200.00 ➝ $190.00
8/10/2026
Albemarle Corporation stock logo
ALB
Albemarle
Lower Price TargetOutperform$166.00 ➝ $157.00
8/10/2026
Albemarle Corporation stock logo
ALB
Albemarle
Reiterated RatingReduce$161.00
8/7/2026
Albemarle Corporation stock logo
ALB
Albemarle
Lower Price TargetBuy$205.00 ➝ $175.00
8/7/2026
Albemarle Corporation stock logo
ALB
Albemarle
Lower Price TargetBuy$225.00 ➝ $175.00
8/7/2026
Albemarle Corporation stock logo
ALB
Albemarle
Lower Price TargetBuy$245.00 ➝ $225.00
8/6/2026
SmartRent, Inc. stock logo
SMRT
SmartRent
DowngradeSell (D-)Sell (E+)
8/4/2026
Albemarle Corporation stock logo
ALB
Albemarle
Reiterated RatingSell (D+)
7/28/2026
Albemarle Corporation stock logo
ALB
Albemarle
Reiterated RatingOutperform
7/28/2026
Albemarle Corporation stock logo
ALB
Albemarle
Lower Price TargetSector Outperform$215.00 ➝ $200.00
7/21/2026
SmartRent, Inc. stock logo
SMRT
SmartRent
UpgradeSell (E+)Sell (D-)
(Data available from 8/11/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Albemarle Corporation stock logo
ALB
Albemarle
$5.14B3.01$6.36 per share20.65$64.12 per share2.05
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
N/AN/AN/AN/A$0.11 per shareN/A
SmartRent, Inc. stock logo
SMRT
SmartRent
$152.33M1.70N/AN/A$1.23 per share1.10
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Albemarle Corporation stock logo
ALB
Albemarle
-$510.63M$0.27486.2810.53N/A3.09%10.96%5.39%N/A
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
-$24.20M-$0.28N/AN/AN/AN/A-229.43%-165.60%8/13/2026 (Estimated)
SmartRent, Inc. stock logo
SMRT
SmartRent
-$60.56M-$0.10N/AN/AN/A-12.97%-8.50%-6.27%N/A

Latest ALB, CRDL, SMRT, and CRTA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/13/2026Q2 2026
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
-$0.09N/AN/AN/AN/AN/A
8/5/2026Q2 2026
Albemarle Corporation stock logo
ALB
Albemarle
$3.20$3.75+$0.55$3.52$1.61 billion$1.74 billion
8/5/2026Q2 2026
SmartRent, Inc. stock logo
SMRT
SmartRent
-$0.02-$0.03-$0.01-$0.03$39.62 million$38.39 million
5/11/2026Q1 2026
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
-$0.07-$0.07N/A-$0.07N/AN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Albemarle Corporation stock logo
ALB
Albemarle
$1.621.23%+1.02%600.00%30 Years
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
N/AN/AN/AN/AN/A
SmartRent, Inc. stock logo
SMRT
SmartRent
N/AN/AN/AN/AN/A

Latest ALB, CRDL, SMRT, and CRTA Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/21/2026
Albemarle Corporation stock logo
ALB
Albemarle
quarterly$0.411.38%9/11/20269/11/202610/1/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Albemarle Corporation stock logo
ALB
Albemarle
0.22
2.09
1.35
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
N/A
4.39
4.39
SmartRent, Inc. stock logo
SMRT
SmartRent
N/A
3.80
3.30

Institutional Ownership

CompanyInstitutional Ownership
Albemarle Corporation stock logo
ALB
Albemarle
92.87%
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
12.49%
SmartRent, Inc. stock logo
SMRT
SmartRent
59.42%

Insider Ownership

CompanyInsider Ownership
Albemarle Corporation stock logo
ALB
Albemarle
0.42%
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
5.25%
SmartRent, Inc. stock logo
SMRT
SmartRent
2.30%
CompanyEmployeesShares OutstandingFree FloatOptionable
Albemarle Corporation stock logo
ALB
Albemarle
7,800118.00 million117.51 millionOptionable
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
20115.89 million109.80 millionNot Optionable
SmartRent, Inc. stock logo
SMRT
SmartRent
640191.61 million187.21 millionOptionable

Recent News About These Companies

SmartRent Q2 Earnings Call Highlights
SmartRent, Inc. (SMRT) Q2 2026 Earnings Call Transcript
SmartRent Reports Second Quarter 2026 Financial Results
SmartRent (SMRT) to Release Earnings on Wednesday
SmartRent, Inc. (NYSE:SMRT) Short Interest Update
SmartRent Launches Hardware-Free Virtual Intercom

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Albemarle stock logo

Albemarle NYSE:ALB

$131.29 +0.18 (+0.14%)
Closing price 08/10/2026 03:58 PM Eastern
Extended Trading
$131.18 -0.11 (-0.08%)
As of 04:38 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services. The Specialties segment provides bromine-based specialty chemicals, including elemental bromine, alkyl and inorganic bromides, brominated powdered activated carbon, and other bromine fine chemicals; lithium specialties, such as butyllithium and lithium aluminum hydride; develops and manufactures cesium products for the chemical and pharmaceutical industries; and zirconium, barium, and titanium products for pyrotechnical applications that include airbag initiators. The Ketjen segment offers clean fuels technologies (CFT), which is composed of hydroprocessing catalysts (HPC) together with isomerization and akylation catalysts; fluidized catalytic cracking (FCC) catalysts and additives; and performance catalyst solutions (PCS), which is composed of organometallics and curatives. The company serves the energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection markets. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.

Cardiol Therapeutics stock logo

Cardiol Therapeutics NASDAQ:CRDL

$1.47 +0.05 (+3.52%)
As of 08/10/2026 04:00 PM Eastern

Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product CardiolRx, which is in Phase II multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada.

SmartRent stock logo

SmartRent NYSE:SMRT

$1.36 -0.07 (-4.58%)
As of 08/10/2026 03:58 PM Eastern

SmartRent, Inc., an enterprise software company, provides an integrated smart home operating system to residential property owners and operators, homebuilders, institutional home buyers, developers, and residents in the United States. The company's products and solutions include smart apartments and homes, access control for buildings, common areas, and rental units, asset protection and monitoring, parking management, self-guided tours, and community and resident Wi-Fi. It also offers professional services to customers, which include training, installation, and support services. The company was founded in 2017 and is headquartered in Scottsdale, Arizona.